Senator Jacky Rosen (D-NV) presents a largely clean profile on self-dealing metrics. Her investments are concentrated in mutual funds rather than individual stocks; she has not personally bought a stock since taking office and has cosponsored the ETHICS Act to ban congressional stock trading. Her primary documented issues are administrative: late STOCK Act reporting of automatic (corporate-action) trades in 2017, and amending her financial disclosures back to 2018 to add her "trustee" title for a family trust whose existence and assets she had already disclosed. Industry-donation patterns (securities/investment lead her donor base) reflect typical incumbent fundraising and constitute correlation, not proof of influence; no credible evidence was found of campaign-fund personal use, family lobbying, or fundraising-driven vote absenteeism.
Public record
In Congress since
2017
Committees
Armed Services Commerce, Science, and Transportation Foreign Relations Small Business and Entrepreneurship
Missed votes, 119th Congress
1.5% (14 of 915; median member 1.9%)
Campaign money, 2025–26 cycle
$1.5M raised · 13% from PACs & committees · $1.1M cash on hand FEC ↗
The stock-trading ban
Senate cloture on H.R. 7008, Sep 30, 2026
No
Cosponsored a ban bill
None
H.R. 7008 bans new stock purchases by members, spouses and dependents; it doesn't force sales of existing holdings. The Senate vote was on the version paired with the SAVE Act, which is why no Democrat voted yes. Full breakdown →
Disclosed stock trades
No periodic transaction reports on file since 2024. That's the norm: most members don't trade individual stocks, or hold them in blind trusts and diversified funds.
Amounts are the ranges members must report, not exact values. The STOCK Act requires a report within 45 days of a trade; "late" counts days past that deadline, measured to the filing date.
How the score breaks down
Stock self-trading
25% weight
12
Holdings are dominated by mutual funds, not individual equities. Rosen has not personally bought a stock since taking office and not sold one in over five years. Her only flagged STOCK Act issue: 2017 late reporting of two ~$15K transactions (LogMeIn, Spectra Energy) that were automatic corporate-action trades, reported 50-68 days late. No evidence of suspicious timing, committee-sector overlap, or market-beating active trading. Low score reflects only the historic late-filing lapse.
Rosen entered office already wealthy (est. ~$10.8M in 2018; ~$6.7M-$20.5M range for 2023). Pre-office wealth is not scored per rubric, and disclosure ranges are too wide to isolate growth beyond salary/market gains. No evidence of enrichment attributable to office. Scored 0 for absence of disqualifying data.
Money → action alignmentcorrelation, not proof of any quid-pro-quo
20% weight
25
CORRELATION, NOT PROOF. Securities & Investment is the top industry contributor to her joint fundraising committee (~$635K in 2024). She sits on Armed Services, Commerce, and Foreign Relations committees, which overlap with finance/defense/tech donor interests. No specific documented quid-pro-quo or anomalous vote tied to a donor was found; score reflects ordinary concentration of incumbent industry money without demonstrated vote-buying.
No evidence found of campaign or leadership-PAC funds spent on personal benefit. An FEC matter (MUR 7358) referenced excessive in-kind contributions via third-party legal-expense payments, which is a contribution-limit issue, not personal use of campaign money. Rosen has publicly pushed legislation against wasteful campaign self-promotion spending. Scored 0 for absence of disqualifying evidence.
No evidence of family lobbying, government contracts tied to her office, or a documented staff-to-lobbyist pipeline. Her husband Larry Rosen is a radiologist; her pre-office consulting clients (1993-2002) predate her tenure. The only related item is an administrative failure to list her 'trustee' title for a family trust she had otherwise disclosed since 2016 - not a lobbying/contract conflict. Scored 0 for absence of disqualifying evidence.
Rosen raised heavily during her 2024 reelection (~$7.6M in Q2 2024), but no evidence links fundraising to abnormal vote absenteeism. A documented Senate absence was due to a medical injury, not fundraising. No paid-speech income or systematic missed-vote pattern found. Scored 0 for absence of disqualifying data.
Sources behind this score: 3 news reporting · 1 data aggregator · 3 reference database · 1 official record. Score = weighted average of the components that have data; the 4 without sourced evidence are excluded, never counted against the member. Methodology →
Embed this score on your site
Updates automatically when the score changes.
Right of reply
Is something here wrong or missing context? Members and their staff can send a correction or a statement. Statements are published on this page in full, and corrections go in the public log. Email corrections@greederboard.com.
